Development of a prognostic Risk Classification for biochemical Recurrence after PSMA-PET-based Radiotherapy in Patients with oligometastatic Prostate Cancer.

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions